Epidemiological Studies of Esophageal Cancer in the Era of Genome-wide Association Studies

Overview

Journal World J Gastrointest Pathophysiol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Aug 19

PMID 25133033

Citations 25

Authors

An-Hui Wang

Yuan Liu

Bo Wang

Yi-Xuan He

Ye-Xian Fang

Yong-Ping Yan

Affiliations

Soon will be listed here.

Abstract

Esophageal cancer (EC) caused about 395000 deaths in 2010. China has the most cases of EC and EC is the fourth leading cause of cancer death in China. Esophageal squamous cell carcinoma (ESCC) is the predominant histologic type (90%-95%), while the incidence of esophageal adenocarcinoma (EAC) remains extremely low in China. Traditional epidemiological studies have revealed that environmental carcinogens are risk factors for EC. Molecular epidemiological studies revealed that susceptibility to EC is influenced by both environmental and genetic risk factors. Of all the risk factors for EC, some are associated with the risk of ESCC and others with the risk of EAC. However, the details and mechanisms of risk factors involved in the process for EC are unclear. The advanced methods and techniques used in human genome studies bring a great opportunity for researchers to explore and identify the details of those risk factors or susceptibility genes involved in the process of EC. Human genome epidemiology is a new branch of epidemiology, which leads the epidemiology study from the molecular epidemiology era to the era of genome wide association studies (GWAS). Here we review the epidemiological studies of EC (especially ESCC) in the era of GWAS, and provide an overview of the general risk factors and those genomic variants (genes, SNPs, miRNAs, proteins) involved in the process of ESCC.

Citing Articles

Risk of serum circulating environmental chemical residues to esophageal squamous cell carcinoma: a nested case-control metabolome-wide association study.

Wang X, Guan P, You L, Qin W, Li Q, Wang X Anal Bioanal Chem. 2025; .

PMID: 39939416 DOI: 10.1007/s00216-025-05784-5.

Design, synthesis and anticancer activities evaluation of novel pyrazole modified catalpol derivatives.

Kong Y, Liu S, Wang S, Yang B, He W, Li H Sci Rep. 2023; 13(1):7756.

PMID: 37173367 PMC: 10182059. DOI: 10.1038/s41598-023-33403-9.

Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (Review).

Wang X, Song H, Liang J, Jia Y, Zhang Y Mol Med Rep. 2022; 26(6).

PMID: 36239258 PMC: 9607826. DOI: 10.3892/mmr.2022.12871.

Upregulation of hsa_circ_0000977 participates in esophageal squamous cancer progression by sponging miR-874-3p.

Li N, Wu J, Hu B, Lu H, Gao J, Zhu L J Clin Lab Anal. 2022; 36(6):e24458.

PMID: 35476874 PMC: 9169171. DOI: 10.1002/jcla.24458.

New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.

Liu L, Wu J, Shi M, Wang F, Lu H, Liu J Genomics Proteomics Bioinformatics. 2022; 20(4):670-687.

PMID: 35351627 PMC: 9880896. DOI: 10.1016/j.gpb.2021.08.016.

References

Li X, Gao C, Yang Y, Zhou F, Li M, Jin Q . Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer. Aliment Pharmacol Ther. 2013; 39(3):270-81. DOI: 10.1111/apt.12574. View

Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X . MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett. 2013; 342(1):121-9. DOI: 10.1016/j.canlet.2013.08.037. View

Kim T, Grobmyer S, Smith R, Ben-David K, Ang D, Vogel S . Esophageal cancer--the five year survivors. J Surg Oncol. 2011; 103(2):179-83. DOI: 10.1002/jso.21784. View

Zhu Y, Fu L, Chen L, Qin Y, Liu H, Xie F . Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2013; 73(7):2298-309. DOI: 10.1158/0008-5472.CAN-12-2663. View

Wang A, Sun C, Li L, Huang J, Chen Q, Xu D . Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. World J Gastroenterol. 2004; 10(7):940-4. PMC: 4717108. DOI: 10.3748/wjg.v10.i7.940. View

Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X . MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013; 74(9):1199-205. DOI: 10.1016/j.humimm.2013.06.012. View

Duan F, Xie W, Cui L, Wang P, Song C, Qu H . Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. Cancer Epidemiol. 2013; 37(5):647-52. DOI: 10.1016/j.canep.2013.04.009. View

Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y . Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet. 2011; 43(7):679-84. DOI: 10.1038/ng.849. View

Turati F, Edefonti V, Bosetti C, Ferraroni M, Malvezzi M, Franceschi S . Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol. 2013; 24(10):2651-2656. DOI: 10.1093/annonc/mdt280. View

10.

Sakai N, Samia-Aly E, Barbera M, Fitzgerald R . A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013; 23(6 Pt B):512-21. DOI: 10.1016/j.semcancer.2013.08.005. View

11.

Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J . Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013; 23(4):233-42. PMC: 3709543. DOI: 10.2188/jea.je20120162. View

12.

Wang Y, Wu H, Liu Q, Wang C, Fu L, Wang H . Association of CHRNA5-A3-B4 variation with esophageal squamous cell carcinoma risk and smoking behaviors in a Chinese population. PLoS One. 2013; 8(7):e67664. PMC: 3699625. DOI: 10.1371/journal.pone.0067664. View

13.

Wang L, Zhou F, Li X, Sun L, Song X, Jin Y . Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010; 42(9):759-63. DOI: 10.1038/ng.648. View

14.

Matsushima K, Isomoto H, Kohno S, Nakao K . MicroRNAs and esophageal squamous cell carcinoma. Digestion. 2010; 82(3):138-44. DOI: 10.1159/000310918. View

15.

Fan Y, Yuan J, Wang R, Gao Y, Yu M . Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer. 2008; 60(3):354-63. PMC: 2409004. DOI: 10.1080/01635580701883011. View

16.

Wu M, Zhao J, Zhang Z, Han R, Yang J, Zhou J . Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control. 2011; 22(4):649-57. PMC: 3059761. DOI: 10.1007/s10552-011-9737-4. View

17.

Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G . MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene. 2013; 517(2):197-204. DOI: 10.1016/j.gene.2012.12.031. View

18.

Chang J, Huang Y, Wei L, Ma B, Miao X, Li Y . Risk prediction of esophageal squamous-cell carcinoma with common genetic variants and lifestyle factors in Chinese population. Carcinogenesis. 2013; 34(8):1782-6. DOI: 10.1093/carcin/bgt106. View

19.

Wu H, Zheng J, Deng J, Hu M, You Y, Li N . A genetic polymorphism in lincRNA-uc003opf.1 is associated with susceptibility to esophageal squamous cell carcinoma in Chinese populations. Carcinogenesis. 2013; 34(12):2908-17. DOI: 10.1093/carcin/bgt252. View

20.

Khoury M, Dorman J . The Human Genome Epidemiology Network. Am J Epidemiol. 1998; 148(1):1-3. DOI: 10.1093/aje/148.1.1. View